This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Procaps Group Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Camilo Camacho

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	less than a year
Participación del CEO	n/a
Permanencia media de la dirección	less than a year
Promedio de permanencia en la Junta Directiva	less than a year

Actualizaciones recientes de la dirección

Recent updates

CEO

Camilo Camacho (49 yo)

less than a year

Permanencia

Dr. Camilo Camacho serves as Interim Co-Chief Executive Officer at Procaps Group S.A. from January 29, 2025. He was President at Procaps Group, S.A. since April 2021 and served as its Chief Operating Offic...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Alejandro Weinstein	Executive Chairman	less than a year	sin datos	14.07% € 20.2m
Camilo Camacho	Interim Co-Chief Executive Officer	less than a year	sin datos	sin datos
Melissa Angelini	Interim Co-Chief Executive Officer	less than a year	sin datos	sin datos
Daniel Bernal	Interim Chief Financial Officer	less than a year	sin datos	sin datos
Marcela Pagano	Vice-President of Corporate & Legal Affairs	12.1yrs	sin datos	sin datos
Luis Alberto Aragon	Vice-President of International Marketing and R&D	6.1yrs	sin datos	sin datos
Mauricio Caballero	Vice-President of Human Resources	10.5yrs	sin datos	sin datos
Patricio Munoz	Chief Optimization and Rationalization Officer	less than a year	sin datos	sin datos

0.2yrs

Permanencia media

54yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 9X1 no se considera experimentado ( 0.2 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Alejandro Weinstein	Executive Chairman	less than a year	sin datos	14.07% € 20.2m
Daniel Fink	Board Observer	2yrs	sin datos	sin datos
Alberto Eguiguren Correa	Independent Director	2.1yrs	sin datos	sin datos
Jose Guillermo Domke	Director	less than a year	sin datos	sin datos
Nicolas Weinstein	Director	less than a year	sin datos	sin datos
Roberto Albisetti	Independent Director	less than a year	sin datos	sin datos
Ernesto Carrizosa	Director	less than a year	sin datos	sin datos
Jorddy Perez Galindo	Independent Director	less than a year	sin datos	sin datos

0.2yrs

Permanencia media

59yo

Promedio de edad

Junta con experiencia: La junta directiva de 9X1 no se considera experimentada (0.2 años de permanencia promedio), lo que sugiere una nueva junta directiva.

Análisis de la empresa y estado de los datos financieros

Datos	Última actualización (huso horario UTC)
Análisis de la empresa	2025/02/19 05:45
Precio de las acciones al final del día	2025/02/03 00:00
Beneficios	2023/09/30
Ingresos anuales	2022/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

Paquete	Datos	Marco temporal	Ejemplo Fuente EE.UU. ^*
Finanzas de la empresa	10 años	Cuenta de resultados Estado de tesorería Balance	Formulario SEC 10-K Formulario SEC 10-Q
Estimaciones del consenso de analistas	+3 años	Previsiones financieras Objetivos de precios de los analistas	Informes de análisis Blue Matrix
Precios de mercado	30 años	Precios de las acciones Dividendos, escisiones y acciones	Datos de mercado ICE Formulario S-1 de la SEC
Propiedad	10 años	Accionistas principales Información privilegiada	Formulario SEC 4 Formulario SEC 13D
Gestión	10 años	Equipo directivo Consejo de Administración	Formulario SEC 10-K Formulario SEC DEF 14A
Principales avances	10 años	Anuncios de empresas	Formulario SEC 8-K

^* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Procaps Group S.A. está cubierta por 2 analistas. 0 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

Analista	Institución
Brian Kemp Dolliver	Brookline Capital Markets
Samuel Campos Alves	BTG Pactual

This company listing is no longer active

Procaps Group Dirección

Dirección controles de criterios 0/4

Información clave

Actualizaciones recientes de la dirección

Procaps Group S.A. Announces Board Changes

Procaps Group S.A. Appoints Daniel Bernal as the Interim Chief Financial Officer

Procaps Group, S.A. Announces Patricio Vargas Transition from the Role of Chief Financial Officer to Chief Optimization and Rationalization Officer

Procaps Group, S.A. Announces Patricio Vargas Transition from the Role of Chief Financial Officer to Chief Optimization and Rationalization Officer

Procaps Group S.A., Annual General Meeting, Dec 16, 2024

Procaps Group, S.A. Announces Resignation of Board Members

Recent updates

Procaps Group S.A.(OTCPK:PROC.F) dropped from NASDAQ Composite Index

Procaps Group S.A. Announces Board Changes

Procaps Group S.A. Appoints Daniel Bernal as the Interim Chief Financial Officer

Procaps Group, S.A. Announces Patricio Vargas Transition from the Role of Chief Financial Officer to Chief Optimization and Rationalization Officer

Procaps Group, S.A. Announces Patricio Vargas Transition from the Role of Chief Financial Officer to Chief Optimization and Rationalization Officer

Procaps Group S.A., Annual General Meeting, Dec 16, 2024

Procaps Group, S.A. Announces Resignation of Board Members

Procaps Receives Nasdaq Listing Determination, to Request Hearing and Further Stay Pending Hearing

New minor risk - Market cap size

High number of new directors

Investor sentiment deteriorates as stock falls 20%

Investor sentiment improves as stock rises 19%

Procaps Group S.A. Announces Resignation of Ruben Minski as Board of Directors

Investor sentiment deteriorates as stock falls 17%

Hoche Partners Raises Concerns on Shareholder Letter Issued by Procaps Group

High number of new directors

Hoche Partners Criticizes Procaps Group's Majority Shareholder for Mismanagement and Rejection of Financial Restructuring Offer

Procaps Group S.A. Announces Board Changes

Procaps Group S.A. announced delayed 20-F filing

Procaps Group S.A. Provides Earnings Guidance for the Year Ended December 31, 2023

Investor sentiment deteriorates as stock falls 17%

Investor sentiment improves as stock rises 21%

Procaps Group S.A. Announces Formation of Strategic Committee to Explore Value Creation Alternatives

Investor sentiment deteriorates as stock falls 23%

New major risk - Revenue and earnings growth

Hoche Partners Sends a Letter to Procaps Group

Hoche Partners Sends a Letter to Procaps Group

Investor sentiment improves as stock rises 24%

Third quarter 2023 earnings released: EPS: US$0.08 (vs US$0.22 in 3Q 2022)

Investor sentiment improves as stock rises 26%

Procaps Group S.A. Announces Executive Changes, Effective January 15, 2024

Procaps Group S.A. Announces Executive Changes, Effective January 15, 2024

Procaps Group S.A. to Report Q3, 2023 Results on Nov 14, 2023

Investor sentiment deteriorates as stock falls 17%

Investor sentiment improves as stock rises 23%

Procaps Group S.A. Appoints Sandra Sanchez Y Oldenhage as A Director

Investor sentiment deteriorates as stock falls 20%

Second quarter 2023 earnings released: EPS: US$0.27 (vs US$0.068 loss in 2Q 2022)

New major risk - Earnings quality

Procaps Group S.A. to Report Q2, 2023 Results on Sep 05, 2023

Procaps Group S.A., Annual General Meeting, Jun 30, 2023

Procaps Group S.A. to Report Q1, 2023 Results on Jun 05, 2023

Full year 2022 earnings released: EPS: US$0.42 (vs US$1.03 loss in FY 2021)

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 25%

Now 22% undervalued after recent price drop

Investor sentiment improves as stock rises 15%

Less than half of directors are independent

Procaps Group S.A. Announces Board Changes

Procaps Group S.A. (NasdaqGM:PROC) announces an Equity Buyback for 2,000,000 shares, for $5 million.

Investor sentiment deteriorates as stock falls 19%

Now 23% undervalued after recent price drop

Procaps Group Announces Key Changes to the Board of Directors

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released: EPS: US$0.22 (vs US$1.14 loss in 3Q 2021)

Procaps Group S.A. to Report Q3, 2022 Results on Nov 14, 2022

Second quarter 2022 earnings released: US$0.07 loss per share (vs US$0.01 loss in 2Q 2021)

Now 20% undervalued after recent price drop

Procaps Group S.A., Annual General Meeting, Jun 28, 2022

Procaps Group S.A. (NasdaqGM:PROC) entered into an agreenment to acquire Grupo Farmacéutico Somar, Sociedad Anónima Promotora de Inversión de Capital Variable from Advent International Corporation.

Procaps Group S.A. (NasdaqGM:PROC) entered into an agreenment to acquire Grupo Farmacéutico Somar, Sociedad Anónima Promotora de Inversión de Capital Variable from Advent International Corporation.

Full year 2021 earnings released: US$1.03 loss per share (vs US$5.22 loss in FY 2020)

Forecast to breakeven in 2022

Now 21% undervalued after recent price drop

Procaps Group Announces Appointment of Melissa Angelini as Investor Relations Director

Procaps Group, S.A. (NasdaqGM:PROC) acquired 86,000 sq. ft. Pharmaceutical Production Facility Located in West Palm Beach, Florida from Strides Pharma Inc.

Less than half of directors are independent

CEO